Triple-negative breast cancer: from classical clinicopathological features to androgen receptor profile
Romanian Journal of Morphology and Embryology · 2024
DOI: 10.47162/rjme.65.2.07 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Morphology and Embryology, 2024. Verfasst von Iulian Prutianu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morpho-Functional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Iaşi, Romania; simonaelizagiusca@gmail.com; bianca.m…. Hauptthemen laut MEDLINE: Receptors, Androgen, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Triple-negative breast cancer (BC) represents an extensively analyzed entity to establish the overall framework of clinicopathological characteristics, with an impact on defining prognostic and predictive factors. The relationship between triple-negative BC and androgen receptor (AR) is far from being clarified. We aimed to evaluate the classical clinicopathological spectrum that characterized a triple-negative BC, focusing on AR expression. The study group comprised 124 cases of triple-negative BC. The main clinicopathological parameters were extracted from medical records. The immunohistochemical (IHC) exam was run using the following antibodies: anti-estrogen receptor (ER), anti-progesterone receptor (PR), anti-human epidermal growth factor receptor (HER2/neu), anti-Ki67 and anti-AR. AR immunoexpression was assessed as absent (completely negative) or present (unrelated to percentages and intensity). Data were statistically analyzed. AR expression was positive in 78 (63%) cases and negative in 46 (37%) cases. Among the study group, 28 cases exhibited an AR percentage ranging from 1% to 10%, 15 cases showed a percentage between 11% and 50%, while 12 cases had AR values between 51% and 75% and 23 cases fell within the AR range of 76% to 100%. No significant differences between AR immunoexpression (negative versus positive), clinicopathological characteristics and survival parameters were found. Statistically significant differences were registered between histological type, tumor stage, distant metastasis, tumor-infiltrating lymphocytes (TILs), treatment and residual cancer burden (RCB), and survival parameters. Thus, our results sustain that AR does not affect the biological behavior of triple-negative BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Morpho-Functional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Iaşi, Romania; simonaelizagiusca@gmail.com; bianca.manole@ymail.com.
Zitieren
APA
Prutianu, I., Giuşcă, S. E., Gafton, B., Chifu, M. B., Terinte, C., Antonescu, A., Popovici, L., & Căruntu, I. D. (2024). Triple-negative breast cancer: from classical clinicopathological features to androgen receptor profile. Romanian Journal of Morphology and Embryology. https://doi.org/10.47162/rjme.65.2.07
Vancouver
Prutianu I, Giuşcă SE, Gafton B, Chifu MB, Terinte C, Antonescu A, et al. Triple-negative breast cancer: from classical clinicopathological features to androgen receptor profile. Romanian Journal of Morphology and Embryology. 2024. doi:10.47162/rjme.65.2.07
BibTeX
@article{Prutianu2024,
author = {Prutianu, Iulian and Giuşcă, Simona Eliza and Gafton, Bogdan and Chifu, Mariana Bianca and Terinte, Cristina and Antonescu, Alexandra and Popovici, Larisa and Căruntu, Irina Draga},
title = {Triple-negative breast cancer: from classical clinicopathological features to androgen receptor profile},
journal = {Romanian Journal of Morphology and Embryology},
year = {2024},
doi = {10.47162/rjme.65.2.07}
}
EUVIMED